An up-and-coming liquid nutrition manufacturer with a passionate customer base was working on securing contracts and funding to bring its products into retail stores and grow the overall business. The company needed to better understand its customers, competitors and the untapped market it dreamed of reaching to prove the viability of its growth potential with investors. Although the company initially only wanted help with an immediate communications issue, the relationship quickly deepened and the client began to rely on Escalent to fill in the remaining gaps in market understanding. With every new or persistent issue this brand faced, Escalent was its partner of choice—from informing communications strategies and product development, to measuring consumer and health care professional (HCP) perceptions and attitudes.
Over three years, Escalent designed and executed a collection of qualitative and quantitative research that developed into a 360-degree approach to brand equity.
We established consumer and HCP trackers to measure ever-changing market perceptions. Online qualitative discussions with key customer targets provided a deeper understanding of what drives product recommendations. A consumer journey analysis provided complete insight into how customers shopped for products in the liquid nutrition space and identified which touchpoints are most influential to potential buyers. And a segmentation study identified distinct customer categories and the best outreach strategies.
Escalent’s world-class analysts and marketing scientists led every step of building this holistic approach to brand equity and market landscape.
What began as a “one and done” collaboration resulted in a strong multiyear relationship that is deeply consultative and built on a foundation of trust, respect and results.
The liquid nutrition company has taken every recommendation and insight to heart as it has used every single piece of research in yearly planning, C-suite readouts and investor presentations. The results speak for themselves, with the company successfully raising $100M in funding to support its growth since the foundation of the research relationship with Escalent.
New EVForward study findings reveal an opportunity for OEMs to drive brand affinity and BEV purchase consideration with cross-industry partnerships
How will mRNA transform patient engagement? Learn about mRNA innovation and implications for Pharmaceuticals and Life Sciences brand, marketing, and sales teams.
A series on mRNA innovation in life sciences and biopharma. Check out part two on what the flurry of mRNA clinical trials means for brand, marketing and sales.
Escalent's EV expert is sharing some main highlights that made 2023 a seminal year for battery electric vehicles
The growing competition in the life sciences industry makes customer and patient centricity essential for brands. Find out how brands can fuel customer centricity by diving deep into doctor, patient, and HCP behavior and their journey across multiple touchpoints.
Escalent’s EVForward study finds heavy BEV intenders are more familiar with and closer to buying BEVs than average car shoppers due to more everyday exposure.
Escalent’s Energy expert, Suzanne Haggerty, shares Cogent Syndicated study insights on how utilities can improve communication and customer engagement around their environmental programs
Escalent's Energy expert, Suzanne Haggerty, explores opportunities for utility companies to improve their perceptions with their customers by leveraging data from our Cogent Syndicated study
New Fleet Advisory Hub findings reveal fleet decision-makers’ awareness of telematics service providers and the opportunities for providers to capture and expand their market share
